Please use this identifier to cite or link to this item: http://hdl.handle.net/2440/111461
Citations
Scopus Web of Science® Altmetric
?
?
Type: Journal article
Title: HIF-2α promotes dissemination of plasma cells in multiple myeloma by regulating CXCL12/CXCR4 and CCR1
Author: Vandyke, K.
Zeissig, M.
Hewett, D.
Martin, S.
Mrozik, K.
Cheong, C.
Diamond, P.
To, L.
Gronthos, S.
Peet, D.
Croucher, P.
Zannettino, A.
Citation: Cancer Research, 2017; 77(20):5452-5463
Publisher: American Association for Cancer Research
Issue Date: 2017
ISSN: 0008-5472
1538-7445
Statement of
Responsibility: 
Kate Vandyke, Mara N. Zeissig, Duncan R. Hewett, Sally K. Martin, Krzysztof M. Mrozik, Chee Man Cheong, Peter Diamond, L. Bik To, Stan Gronthos, Daniel J. Peet, Peter I. Croucher and Andrew C.W. Zannettino
Abstract: Disease progression and relapse in multiple myeloma is dependent on the ability of the multiple myeloma plasma cells (PC) to reenter the circulation and disseminate throughout the bone marrow. Increased bone marrow hypoxia is associated with increased recirculation of multiple myeloma PCs. Accordingly, we hypothesized that during chronic hypoxia, activation of HIF-2α may overcome the bone marrow retention signal provided by stromal-derived CXCL12, thereby enabling dissemination of multiple myeloma PCs. Here we demonstrate that HIF-2α upregulates multiple myeloma PC CXCL12 expression, decreasing migration toward CXCL12 and reducing adhesion to mesenchymal stromal cells in vitro We also found that HIF-2α strongly induced expression of the chemokine receptor CCR1 in multiple myeloma PCs. CCR1 activation potently induces multiple myeloma PC migration toward CCL3 while abrogating the multiple myeloma PC migratory response to CXCL12. In addition, increased CCR1 expression by multiple myeloma PCs conferred poor prognosis in newly diagnosed multiple myeloma patients and was associated with an increase in circulating multiple myeloma PCs in these patients. Taken together, our results suggest a role for hypoxia-mediated CCR1 upregulation in driving the egress of multiple myeloma PCs from the bone marrow. Targeting CCR1 may represent a novel strategy to prevent dissemination and overt relapse in multiple myeloma. Cancer Res; 77(20); 5452-63. ©2017 AACR.
Keywords: Tumor Cells, Cultured
Rights: © 2017 American Association for Cancer Research.
RMID: 0030075102
DOI: 10.1158/0008-5472.CAN-17-0115
Grant ID: http://purl.org/au-research/grants/nhmrc/626911
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.